Fielmann Group AGXSWX:FIE 85 Return-on-Tangible-Equity is 71.19% as of Mar. 2026, which is 159% above its 10-year median of 27.48. GuruFocus rates XSWX:FIE with a GF Score™ of 85/100 and a GF Value™ of CHF49.51. The stock has 2 warning signs investors should review. Among 760 Medical Devices & Instruments companies, Fielmann Group AG ranks better than 93.03% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Fielmann Group AG's annualized net income for the quarter that ended in Mar. 2026 was CHF203 Mil. Fielmann Group AG's average shareholder tangible equity for the quarter that ended in Mar. 2026 was CHF285 Mil. Therefore, Fielmann Group AG's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 71.19%.
The historical rank and industry rank for Fielmann Group AG's Return-on-Tangible-Equity or its related term are showing as below:
XSWX:FIE'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 22.94 Med: 27.48 Max: 85.08
Current: 83.01
During the past 13 years, Fielmann Group AG's highest Return-on-Tangible-Equity was 85.08%. The lowest was 22.94%. And the median was 27.48%.
XSWX:FIE's Return-on-Tangible-Equity is ranked better than 93.03% of 760
companies
in the Medical Devices & Instruments industry
Industry Median: 4.115
vs XSWX:FIE: 83.01
Fielmann Group AG (XSWX:FIE) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Fielmann Group AG Return-on-Tangible-Equity Related Terms
Fielmann Group AG Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Fielmann Group AG's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:FIE vs ISRG, BDX, MDLN: Return-on-Tangible-Equity Comparison
For the Medical Instruments & Supplies subindustry, Fielmann Group AG's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fielmann Group AG Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fielmann Group AG's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Fielmann Group AG's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 71.19% mean?
Fielmann Group AG (XSWX:FIE) has a Return-on-Tangible-Equity of 71.19% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Fielmann Group AG and its competitors. This is 159% above median its historical median of 27.48. Over the past decade, Fielmann Group AG's Return-on-Tangible-Equity has ranged from 22.94 to 85.08. According to the industry distribution chart, Fielmann Group AG ranks #53 out of 760 companies in the Medical Devices & Instruments industry, placing it in the top 7%.
Is Fielmann Group AG's Return-on-Tangible-Equity too high?
Fielmann Group AG's current Return-on-Tangible-Equity of 71.19% is 159% above median its 10-year median of 27.48. Over the past 10 years, this metric has ranged from a low of 22.94 to a high of 85.08. The Medical Devices & Instruments industry median Return-on-Tangible-Equity is 4.12. Fielmann Group AG's value of 71.19% is 1630% above this industry median. Based on the distribution chart, Fielmann Group AG ranks #53 out of 760 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Fielmann Group AG has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Fielmann Group AG's Return-on-Tangible-Equity compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Fielmann Group AG ranks #53 out of 760 companies for Return-on-Tangible-Equity. This places Fielmann Group AG in the top 7% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 4.12. Fielmann Group AG's value of 71.19% is 1630% above this benchmark. Historically, Fielmann Group AG's own Return-on-Tangible-Equity has ranged from 22.94 to 85.08 over the past decade. While the company's 10-year median is 27.48 vs. the industry median of 4.12, Fielmann Group AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.12, based on 760 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fielmann Group AG's current Return-on-Tangible-Equity of 71.19% is 1630% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Fielmann Group AG and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fielmann Group AG's current Return-on-Tangible-Equity is 71.19%, which is 159% above median its own 10-year median of 27.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fielmann Group AG stock overvalued right now?
Fielmann Group AG (XSWX:FIE) has a current Return-on-Tangible-Equity of 71.19%. The stock's GF Value™ is CHF49.51, compared to a current price of CHF40.45 — trading 18.3% below its estimated fair value. The current Return-on-Tangible-Equity is 71.19%, which is 159% above median its 10-year median of 27.48 and 1630% above the Medical Devices & Instruments industry median of 4.12. Fielmann Group AG's overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Fielmann Group AG (XSWX:FIE), the current Return-on-Tangible-Equity is 71.19% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fielmann Group AG (XSWX:FIE) Overvalued in 2026?
Based on GuruFocus' analysis, Fielmann Group AG stock appears to be undervalued.
The current stock price of CHF40.45 is trading 18.3% below its estimated GF Value™ of CHF49.51.
Key valuation signals for XSWX:FIE:
Return-on-Tangible-Equity: 71.19% (159% above median its 10-year median of 27.48)
GF Value™: CHF49.51 vs. price of CHF40.45 (18.3% below fair value)
Industry Position: 1630% above the Medical Devices & Instruments median (#53 of 760)
No single metric tells the full story. See the XSWX:FIE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fielmann Group AG is involved in the purchase and sale of goods, in physical stores as well as wholesale and online, particularly in the optometric and hearing acoustics sectors, and especially sales of all kinds of vision aids - particularly glasses, eyeewear frames and lenses, sunglasses, contact lenses, accessories, hearing systems, as well as personal protective equipment. Fielmann is involved in all levels of the optical industry value-added chain: designing, manufacturing, product offering, and optician services. The group was divided into six segments: Germany, Switzerland, Austria, Spain, North America, and Other. The majority of its revenue is generated from Germany.
85GF Score
Get the complete analysis for XSWX:FIE
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:FIE has been successfully added to your 
